Featured Research

from universities, journals, and other organizations

Anti-HIV Protein From Blue-green Algae Also Inhibits Ebola Infection

Date:
March 5, 2003
Source:
NIH/National Cancer Institute
Summary:
Researchers have discovered that a bacterial protein known to reduce the ability of the human immunodeficiency virus (HIV) to infect cells also inhibits infection by the Ebola virus. The antiviral protein, known as cyanovirin-N (CV-N), can extend the survival time of Ebola-infected mice, researchers from the National Cancer Institute's Molecular Targets Discovery Program report in a study published in Antiviral Research.

Researchers have discovered that a bacterial protein known to reduce the ability of the human immunodeficiency virus (HIV) to infect cells also inhibits infection by the Ebola virus. The antiviral protein, known as cyanovirin-N (CV-N), can extend the survival time of Ebola-infected mice, researchers from the National Cancer Institute's Molecular Targets Discovery Program report in a study published in Antiviral Research.

Related Articles


The study, done in collaboration with researchers from the U.S. Army Medical Research Institute of Infectious Diseases, the Centers for Disease Control and Prevention, and the National Institute of Diabetes and Digestive and Kidney Diseases, provides important insights into the process of Ebola infection. There is currently no treatment for Ebola infection, which causes severe and often fatal hemorrhagic fever.

CV-N comes from a type of bacterium known as cyanobacterium, or blue-green algae. Its antiviral properties were originally discovered through NCI's Laboratory of Drug Discovery Research and Development in a screening process designed to identify natural materials that act against HIV. CV-N effectively inhibits HIV infection of cells grown in the laboratory.

"CV-N is extremely effective against a broad range of HIV strains," said Barry O'Keefe, Ph.D., of NCI's Center for Cancer Research, one of the authors of the study. It is currently being investigated in the laboratory as a potential topical microbicide to prevent the sexual transmission of HIV.

CV-N inhibits HIV infection by binding to the outside of the virus and physically blocking it from entering cells. The protein is known to attach to a particular sugar molecule on the virus surface, and because similar sugar molecules coat the Ebola virus, researchers hoped CV-N might have the same effect on Ebola that it does on HIV.

Their hypothesis proved to be true when laboratory experiments revealed that CV-N does bind to the sugar molecules on the outside of the Ebola virus and inhibit its ability to infect cells, much as it does with HIV. Furthermore, when researchers injected CV-N into mice prior to infecting the animals with Ebola, then continued to inject CV-N once a day, the onset of visible illness was delayed and the animals survived longer than those not treated with CV-N.

"CV-N is the first molecule known to inhibit Ebola infection by interfering with the virus's ability to enter cells," said O'Keefe. Although researchers believe it is unlikely that CV-N itself will be an effective treatment for Ebola infection, understanding the specific molecules involved in CV-N's interaction with the virus will help clarify the processes necessary for infection. Scientists are optimistic that this knowledge eventually may lead to useful therapies.

###

For more information about cancer, visit NCI's Web site at http://www.cancer.gov .


Story Source:

The above story is based on materials provided by NIH/National Cancer Institute. Note: Materials may be edited for content and length.


Cite This Page:

NIH/National Cancer Institute. "Anti-HIV Protein From Blue-green Algae Also Inhibits Ebola Infection." ScienceDaily. ScienceDaily, 5 March 2003. <www.sciencedaily.com/releases/2003/03/030305081547.htm>.
NIH/National Cancer Institute. (2003, March 5). Anti-HIV Protein From Blue-green Algae Also Inhibits Ebola Infection. ScienceDaily. Retrieved March 28, 2015 from www.sciencedaily.com/releases/2003/03/030305081547.htm
NIH/National Cancer Institute. "Anti-HIV Protein From Blue-green Algae Also Inhibits Ebola Infection." ScienceDaily. www.sciencedaily.com/releases/2003/03/030305081547.htm (accessed March 28, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, March 28, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) — A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com
WH Plan to Fight Antibiotic-Resistant Germs

WH Plan to Fight Antibiotic-Resistant Germs

AP (Mar. 27, 2015) — The White House on Friday announced a five-year plan to fight the threat posed by antibiotic-resistant bacteria amid fears that once-treatable germs could become deadly. (March 27) Video provided by AP
Powered by NewsLook.com
House Ready to Pass Medicare Doc Bill

House Ready to Pass Medicare Doc Bill

AP (Mar. 26, 2015) — In rare bipartisan harmony, congressional leaders pushed a $214 billion bill permanently blocking physician Medicare cuts toward House passage Thursday, moving lawmakers closer to resolving a problem that has plagued them for years. (March 26) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins